Literature DB >> 6299876

Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features.

P Kerlin, G L Davis, D B McGill, L H Weiland, M A Adson, P F Sheedy.   

Abstract

Based on strict predefined histologic criteria, we identified 23 patients with hepatic adenoma and 41 patients with focal nodular hyperplasia seen at this institution between 1961 and 1980. Patients with hepatic adenoma were young and 91% were female. When a reliable history was available, 89% had used oral contraceptives; 53% presented acutely or with pain. Eleven of 11 radionuclide scans were abnormal; 15 of 15 angiograms showed a hypervascular mass with 7 of 15 showing areas of hypovascularity. Eighteen resections were performed with one operative death. Two tumors contained areas of unequivocal hepatocellular carcinoma. Fifteen of 18 patients followed for 82 +/- 11 mo were living and well and had discontinued oral contraceptives. Focal nodular hyperplasia patients were older, 88% were female, and 58% had used oral contraceptives. Their lesions were discovered accidentally. Seven of 12 radionuclide scans demonstrated voids, while 13 of 13 angiograms showed hypervascular lesions with no areas of hypovascularity. Seventeen tumors were resected. Twenty-three of 24 patients followed for 45 +/- 7 mo were living and well. One died of nonhepatic causes. Based on the findings of this review, we believe that if the clinical suspicion of hepatic adenoma or focal nodular hyperplasia is strong, elective laparotomy for diagnosis is usually the best approach. Hepatic adenoma should be resected if technically feasible. Intraoperative wedge biopsy is appropriate for focal nodular hyperplasia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6299876

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  54 in total

Review 1.  Focal nodular hyperplasia--a review of myths and truths.

Authors:  Christopher B Nahm; Kevin Ng; Philip Lockie; Jaswinder S Samra; Thomas J Hugh
Journal:  J Gastrointest Surg       Date:  2011-09-30       Impact factor: 3.452

Review 2.  Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management.

Authors:  Agustin Cristiano; Agustin Dietrich; Juan Carlos Spina; Victoria Ardiles; Eduardo de Santibañes
Journal:  Updates Surg       Date:  2013-06-27

3.  Gary L. Davis, MD: a conversation with the editor. Interview by William Clifford Roberts.

Authors:  Gary L Davis
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-01

Review 4.  Evaluation of nonmalignant liver masses.

Authors:  Wojciech Blonski; K Rajender Reddy
Journal:  Curr Gastroenterol Rep       Date:  2006-02

5.  Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization.

Authors:  Sawako Kobayashi; Hiroki Sakaguchi; Masaki Takatsuka; Takehisa Suekane; Shuji Iwai; Hiroyasu Morikawa; Masaru Enomoto; Akihiro Tamori; Norifumi Kawada
Journal:  Hepatol Int       Date:  2009-03-05       Impact factor: 6.047

6.  Malignant transformation of hepatocellular adenoma: how frequently does it happen?

Authors:  M Kudo
Journal:  Liver Cancer       Date:  2015-03       Impact factor: 11.740

7.  Liver cell adenoma in a young man with elevated serum PIVKA-II level.

Authors:  H Uto; M Shigehira; T Kawano; H Nagatomo; T Kuribayashi; S Taniguchi; K Koga; N Komada; T Kitamura; T Maruyama; H Tsubouchi
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

8.  Liver cell adenoma showing sequential alteration of radiological findings suggestive of well-differentiated hepatocellular carcinoma.

Authors:  Takayuki Kogure; Yoshiyuki Ueno; Satoshi Sekiguchi; Kazuyuki Ishida; Takehiko Igarashi; Yuta Wakui; Takao Iwasaki; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

9.  Indication for treatment and long-term outcome of focal nodular hyperplasia.

Authors:  Glenn K Bonney; Dhanwant Gomez; Ahmed Al-Mukhtar; Giles J Toogood; J Peter A Lodge; Raj Prasad
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 10.  Distinguishing benign from malignant liver tumours.

Authors:  Jay P Heiken
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.